Donor-specific human leukocyte antigen antibodies and late graft fibrosis after pediatric liver transplantation: Time-associated variables or cause and effect?

Liver Transplantation

Volumn 18, Issue 11, 2012, Pages 1270-1271

  Lohlun, John C ^a   Matas, Arthur J ^a   Chinnakotla, Srinath ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C4D; HLA ANTIBODY; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2;

ALLOIMMUNITY; CHRONIC GRAFT REJECTION; COMPLEMENT ACTIVATION; COMPLEMENT DEPOSITION; DISEASE SEVERITY; EDITORIAL; GRAFT DYSFUNCTION; GRAFT FIBROSIS; GRAFT RECIPIENT; HISTOPATHOLOGY; HLA SYSTEM; HUMAN; LIVER BIOPSY; LIVER TRANSPLANTATION; PRIORITY JOURNAL; SCORING SYSTEM;

FEMALE; GRAFT REJECTION; HLA ANTIGENS; HUMANS; LIVER TRANSPLANTATION; MALE;

EID: 84868125091     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.23556     Document Type: Editorial

References (10)

1. Organ Procurement and Transplantation Network and Scientific Registry of Transplant Recipients 2010 data report. Am J Transplant 2012; 12 (suppl 1): 1-156.
2. Ekong UD, Melin-Aldana H, Seshadri R, Lokar J, Harris D, Whitington PF, Alonso EM,. Graft histology characteristics in long-term survivors of pediatric liver transplantation. Liver Transpl 2008; 14: 1582-1587.
3. Scheenstra R, Peeters PM, Verkade HJ, Gouw AS,. Graft fibrosis after pediatric liver transplantation: ten years of follow-up. Hepatology 2009; 49: 880-886.
4. Miyagawa-Hayashino A, Yoshizawa A, Uchida Y, Egawa H, Yurugi K, Masuda S, et al. Progressive graft fibrosis and donor-specific human leukocyte antigen antibodies in pediatric late liver allografts. Liver Transpl 2012; 18: 1333- 1342.
5. Gordon RD, Fung JJ, Markus B, Fox I, Iwatsuki S, Esquivel CO, et al. The antibody crossmatch in liver transplantation. Surgery 1986; 100: 705-715.
6. O'Leary JG, Kaneku H, Susskind BM, Jennings LW, Neri MA, Davis GL, et al. High mean fluorescence intensity donor-specific anti-HLA antibodies associated with chronic rejection postliver transplant. Am J Transplant 2011; 11: 1868-1876.
7. Fontana M, Moradpour D, Aubert V, Pantaleo G, Pascual M,. Prevalence of anti-HLA antibodies after liver transplantation. Transpl Int 2010; 23: 858-859.
8. Taner T, Gandhi MJ, Sanderson SO, Poterucha CR, De Goey SR, Stegall MD, Heimbach JK,. Prevalence, course and impact of HLA donor-specific antibodies in liver transplantation in the first year. Am J Transplant 2012; 12: 1504-1510.
9. Magee JC,. Graft fibrosis in stable pediatric liver transplant recipients: what does it mean? Hepatology 2009; 49: 726-728.
10. Feng S, Ekong UD, Lobritto SJ, Demetris AJ, Roberts JP, Rosenthal P, et al. Complete immunosuppression withdrawal and subsequent allograft function among pediatric recipients of parental living donor liver transplants. JAMA 2012; 307: 283-293.